Importance of stoichiometry in cells science: iPSC, CNS leukocytes, and more

Abstract

the hope of becoming the source and basis of sideeffect–free ‘‘medication’’ and repair of deficits in our body,stem cells have been, for a few decades, of interest in basic cellresearch, regenerative medicine, and public opinion. Cytome-try was from the beginning a guiding technology in thisendeavor. The substantial past and present scientific interest isreflected by the fact that publications on stem cells and theirunequivocal identification are the ‘‘best sellers’’ regarding cita-tion and download rates also in the cytometry-focused litera-ture (1). Nevertheless, stem cell therapy still plays a minor rolein clinical practice. The main stem cell therapy is allogenic orautologous bone marrow transplantation in cancer or insevere life-threatening autoimmune diseases such as rheuma-toid arthritis. This transplantation is either done by crudebone marrow allografting or by using purified (i.e., sorted orotherwise enriched) material.Another far less frequent application is transplantation offetal brain tissue in Parkinson’s disease, rendering (temporary)relief from the symptoms. Fetal brain transplant in Hunting-ton’s disease was far less successful as indicated by clinicaltrials enrolling a limited number of patients. In addition,transplantation of parts of the fetal brain is a continuing issueof ethical concern. One of the reasons for the limited applica-tion of stem cell therapy in regenerative medicine is the limita-tion of appropriate cell sources. Mesenchymal stem cells fromfatty tissue (2), as one example, can be relatively easily har-vested but may be limited in their regenerative abilities.Consequently, the discovery of embryonic pluripotentstem cells has led to both a great deal of activity and hype inresearch for novel cell-based therapies. As ethical issuesinvolved in using embryonic stem cells exist, only a limitednumber of countries equipped with appropriate high-endresearch knowledge and technology can embrace these cells fortherapy development.Therefore, the discovery of inducible pluripotent stemcells (iPSCs)—somatic cells (of in principle any type) that canbe reprogrammed by the transfection of a limited number oftranscription factors to become pluripotent—was an impor-tant breakthrough. By their creative and diligent work, thegroup of Shinya Yamanaka from Kyoto University in Japandiscovered that the transfection of only four genes was suffi-cient to reprogram somatic cells to become iPSCs and formany possible cell type of an organism (3).How to optimize the process of transfection to producemaximum numbers of reprogrammed cells and how to per-form appropriate quality control of yield and cell type remainsa central issue. Tiemann and coworkers from Hannover andM€unster in Germany (this issue, page 426) developed a poly-chromatic flow cytometry approach by attaching each of thefour transfected transcription factors (Oct4, c-Myc, Sox2, andKlf4) to four different fluorescent proteins. Quadruplet posi-tive cells contain the reprogrammed iPSCs that can then besorted and cloned. By testing different stoichiometric combi-nations of these transcription factor expression levels,the authors were able to optimize iPSC yield and quantitateoptimal transcription factor levels.The importance of polychromatic cytometry has beenapplied to identify unusual biological material in the pri-mate brain. Bischoff from the University of G€ottingen,Germany and colleagues (this issue, page 436) focusedtheir interest on cells of the immune system infiltratingthe brain. The quantity and composition of these cells canrender information on inflammation processes in neuro-logical diseases and also in stem cell transplantation,